Vice President, Consulting
Kevin leads Lux Research’s dedicated global team of expert consultants that help top executives in the Innovation 1000 make critical decisions about markets, technologies, and strategy to better position existing businesses for growth and to launch new businesses wisely. Kevin and his team help our many clients size and prioritize addressable markets, correctly interpret the competitive landscape, anticipate disruptive technologies and companies, and develop sound go-to-market and business development strategies.
Kevin has more than 20 years of industry experience in the healthcare IT, biotechnology, and market intelligence industries. Prior to Lux Research, he served as VP of Advisory Services at Decision Resources, a leading pharmaceutical market research and intelligence company helping the world’s biopharmas optimize therapeutic pipelines using modeling and forecasting. He also co-founded and led a healthcare data transformation company and prior to that spent more than 10 years in biopharmaceutical discovery research working in neurodegenerative and metabolic diseases. He has been an invited speaker and panel chair at the Harvard Business School and the MIT Sloan School of Business.